Characteristics of study population.

<p>Abbreviations: CVD, cardiovascular disease; BP, blood pressure; iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; ABI, ankle-brachial index; RAS, renin-angiotensin system.</p><p>Characteristics of study population.</p

Cox proportional hazards regression analysis for all-cause mortality.

<p>Abbreviation: CVD, cardiovascular disease; BP, blood pressure; RAS, renin-angiotensin system; iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; PAOD, peripheral arterial occlusion disease.</p><p>Cox proportional hazards regression analysis for all-cause mortality.</p

Cox proportional hazards regression analysis for cardiovascular mortality.

<p>Abbreviation: CVD, cardiovascular disease; BP, blood pressure; RAS, renin-angiotensin system; PAOD, iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; peripheral arterial occlusion disease.</p><p>Cox proportional hazards regression analysis for cardiovascular mortality.</p

Probabilities of overall survival according to dominance side of ABI value.

<p>(A) in all patients with log-rank test: χ² = 1.32; <i>P</i> = 0.249; (B) in patients without PAOD with log-rank test: χ² = 3.47; <i>P</i> = 0.062; (C) in patients with PAOD with log-rank test: χ² = 0.20; <i>P</i> = 0.651.</p

Characteristics of patients at inclusion according to the location of PAOD.

<p>Abbreviations: CVD, cardiovascular disease; BP, blood pressure; iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; RAS, renin-angiotensin system</p><p>*Comparison between all four groups</p><p>^# Comparison between all groups except non-PAOD group.</p><p>Characteristics of patients at inclusion according to the location of PAOD.</p

Kaplan—Meier survival curves.

<p>Probabilities of (A) overall survival with log-rank test: χ² = 60.89; <i>P</i> ≤ 0.001 in the four groups and χ² = 2.02; <i>P</i> = 0.364 in the three PAOD groups. (B) Cardiovascular survival with log-rank test: χ² = 45.24; <i>P</i> ≤ 0.001 in the four groups and χ² = 0.69; <i>P</i> = 0.708 in the three PAOD groups.</p

Number of ischemic stroke events, the hazard ratio of stroke for the matched Tuberculosis (TB) and Non-TB groups.

<p>Number of ischemic stroke events, the hazard ratio of stroke for the matched Tuberculosis (TB) and Non-TB groups.</p

Crude and adjusted hazard ratios of hemorrhagic stroke during the two-year follow-up for the migraine subgroups.

*<p>Variables included in the multiple regression analyses were age, sex, hypertension (with and without medication), diabetes, hyperlipidemia, coronary heart disease, chronic rheumatic heart disease, other heart disease, and the use of anticoagulant medication.</p>†<p>P<0.05;^‡P<0.0001.</p><p>Abbreviations: HS, hemorrhagic stroke; MA, migraine with aura; MO, migraine without aura; MU, uncategorized migraine.</p

Demographic and clinical characteristics of the migraine and non-migraine groups.

<p>Note: Values are expressed as the mean ± SD or n (%).</p

Three-year ischemic stroke-free survival rates for the tuberculosis group (dotted line) and the non-tuberculosis group (solid line).

<p>Three-year ischemic stroke-free survival rates for the tuberculosis group (dotted line) and the non-tuberculosis group (solid line).</p